Evolus EOLS
NASDAQ EOLS
$7.14 -0.55 (-7.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Evolus (EOLS) Selling, General & Administrative (2017 - 2026)

Updated

Evolus' Selling, General & Administrative came in at $57.05 million for Q2 2026, up 0.7% from $56.68 million a year earlier and up 9.8% from the prior quarter.

Analysis

Evolus (EOLS) Selling, General & Administrative (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Evolus reported Selling, General & Administrative of $216.5 million, up 0.2% year-over-year; for FY2025, it came in at $220.79 million, up 11.5% from FY2024.

  • Selling, General & Administrative has increased in each of the last five years, with a five-year compound annual growth rate of 17.6% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $198.03 million in FY2024 (+20.1%), $164.94 million in FY2023 (+16.3%), $141.84 million in FY2022 (+26.6%) and $112.07 million in FY2021 (+14.1%).
  • The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q1 2017.
  • Year-over-year, Selling, General & Administrative increased in seven of the last eight quarters, with growth averaging 9.8%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q1 2022 (growth of 61.8%), and the weakest in Q1 2026 (a decline of 8.2%).
  • Business Quant data shows EOLS's Selling, General & Administrative at $51.98 million (Q1 2026), $54.66 million (Q4 2025) and $52.82 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Evolus 471.34 Mn 279.03 Mn 57.18 Mn 57.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 57.05 Mn
Mar 31, 2026 51.98 Mn
Dec 31, 2025 54.66 Mn
Sep 30, 2025 52.82 Mn
Jun 30, 2025 56.68 Mn
Mar 31, 2025 56.64 Mn
Dec 31, 2024 50.24 Mn
Sep 30, 2024 52.51 Mn
Jun 30, 2024 50.15 Mn
Mar 31, 2024 45.12 Mn
Dec 31, 2023 43.06 Mn
Sep 30, 2023 43.33 Mn
Jun 30, 2023 41.17 Mn
Mar 31, 2023 37.38 Mn
Dec 31, 2022 36.73 Mn
Sep 30, 2022 34.79 Mn
Jun 30, 2022 36.88 Mn
Mar 31, 2022 33.44 Mn
Dec 31, 2021 33.27 Mn
Sep 30, 2021 31.67 Mn
API Access

Evolus Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=EOLS&period=max&api_key=YOUR_API_KEY